Member Info for Kaeren

Saint , it shouldnt be a case of not getting straight answers. I expect Nada on cash at bank , very limited inf on DHSC dispute , but products , direction of company , where we sit with LFT'S should all be open for discussion.

Just thinking about the questions submitted and we can usually submit questions whilst a webinair is live. Think if we can we should ask about patents and what they are for , like this one
https://twitter.com/Blad3sharp/status/1422148316930920449?s=20
Courtesy Bladesharp. It is in the public domain so they should answer.
I will mail Mandy now even though past deadline. K

Genemeanie done a very similar thing. K

Thank you Jungla.

BH2SH2
https://www.dawn.com/news/1639924

BH2 , read that and they were utilising Citilabs but Promate would be ideal.

No idea how accurate this is, hopefully not !!!
https://swprs.org/covid-vaccines-the-good-the-bad-the-ugly/

https://g.co/kgs/YV4Vpx

Umm Naewise , perhaps the Pfizer and others should have a similar date , we already know boosters start Sept for vunerable.

Morning Jungla , where are you seeing that written or is it something you just know? Thanks K

https://www.openaccessgovernment.org/global-bioinformatics-surveillance-sars-cov-2-variant-detection-tests/110403/
Heard an awful lot about this but not been told anything about where it is been used or how lucrative it is ?

The sp fall could be added into question 5 saying we believe the dramatic sp fall is in part due to lack of information, also Porky not just contracts over a certain amt but new product releases and their intended use / target market.
Question 1
We need to know sales not just manufacturing. 1000 on a shelf don't help us.
Question 3
Can you incorporate the higher rate of tax question in here.
Question 7
Can you include here are there any plans to simplify the Winterplex testing process ( like PROmate)
Question 8
Can we ask who is the chief negotiator facing off against DHSC ( excluding lawyer) additionally is the incoming CEO in agreement with the replacement goods figures told to shareholders and does he too believe the dispute will be settled in Novacyts favour. If the incoming CEO intends to adopt a diff strategy to the DHSC resolution , then when as shareholders will we be informed?
9. Can we add tests related to transplants here and include the question what percentage of R & D team work on non covid related products.
Def think we need much more inf on all these new sales staff and what they are tasked with achieving.
No further questions I posted mine on lse last week. Thank you Porky.

Because Covid0 , not all shareholders will raise questions and one can but try , one certainty is if you don't ask you wont get .

Hi Gggg21 why are you telling people that I am a poster called Walsh and Stevo ? I have had two mail exchanges with Walsh ever when he sent me out of the blue a FOI request which I then sent to several posters I communicate with regularily
Whats the game ?

Think goingdowns name speaks for itself , not a name one would choose as an investor in a company.
RB is indeed a new avator for an old poster . Very knowledgeable but adding his/her slant a bit like statistics that can be presented in many ways or come to think of it a rugby ball , you can put one hell of a spin on it
K

12.32 exactly Bluelight big money in private sales both travel and private hospitals are huge revenue earners , Promate will be a huge money spinner. Waiting ignoring the noise.

Correct EXMEX.
Agree BH2SH2 that news was worthy of an RNS and a question they should be able to answer.
Wilson good news about Katalyst again! Anyone got any idea about bed capacity for any of these private hospitals , as all in patients will require regular testing. I believe I've read that the NHS will utilise private hospitals on a continual basis to clear backlogs of surgical cases, so very lucrative if we are supplying !!
I would like to know how many q32 and q16's the company have sold since acquiring IT IS and how many of each they hold as stock.
Infact what are the top ten products they hold and what approximately does that equate to in retail value.
I would also like to know when they intend to apply for U.S approval for Winterplex and how long do they envisage that process will take.
Where exactly is the home use LFT in the approval process and why can we not see the professional use LFT for sale ?
Which distributors, top ten generate the most income for the company ?
Will the company commit to informing the shareholders of any contracts wins over two million ?
Can the company inform the shareholders as to what % of the R & D team are focused on non covid related products ?
Can the company inform the shareholders how many of the staff are sales staff and the breakdown of their target customers at a high level , 20 % NHS , 20% private , 10% U.S ......

Disagree 100 %. I don't want the company taken out for a lowball offer.
However the amt in dispute is insignificant if a bidder wants a world class diagonostic company to add to their market offerings. The earning potential is huge and the R&D firstclass as has been proven numerous times.
Just imo.

Porks fishing

Oh it will all be alright we are borrowing stuff from Wales. We have our own brilliant diagnostic companies , have bought Chinese crap and now no doubt cos they have major OUTBREAKS in China they aren't supplying. My blood a bubbling too Poidster.